Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)

12/01/2013 - "The introduction of the 7-valent pneumococcal vaccine (PCV7) in Canada was very effective in reducing invasive pneumococcal disease (IPD) in children; however, increases of non-PCV7 serotypes have subsequently offset some of these reductions. "
03/02/2012 - "After introduction of current pneumococcal vaccines, a marked decrease in the incidence of pneumococcal disease was observed. "
11/01/2003 - "The 23-valent pneumococcal polysaccharide vaccine has proven consistently effective in preventing invasive pneumococcal disease. "
01/01/2001 - "With the pneumococcal vaccine's safety profile and proven efficacy against invasive disease in appropriate populations, it is imperative that the medical community improve its effort to vaccinate those individuals considered to be at risk for life-threatening pneumococcal disease."
01/01/2023 - "Pneumococcal vaccines have contributed to a significant reduction in pneumococcal disease (PD) in children and adults, including those with SCD. "

12/01/1993 - "The efficacy of pneumococcal vaccines in preventing non-bacteremic pneumonia in high-risk subjects, however, has not been proven. "
03/18/2016 - "Data on the efficacy of the 23-valent pneumococcal polysaccharide vaccine (PPV-23) in preventing adult community-acquired pneumonia (CAP) among the target population of individuals aged over 65 years and high-risk individuals aged 19-64 years are conflicting. "
01/01/2019 - "Nonetheless, existing pneumococcal vaccines are less effective against pneumonia than invasive diseases and serotype replacement is a major concern. "
07/01/2007 - "The flu and pneumococcal vaccines provide some protection against it, but pneumonia is still a major cause of death."
08/01/2013 - "The 23-valent pneumococcal vaccine has been shown to be effective in reducing mortality and complications from pneumonia. "

12/01/1993 - "Pneumococcal vaccines have been proven to be effective in preventing the invasive complications of S pneumoniae infection. "
01/01/2019 - "An effective pneumococcal vaccine would be targeted to the mucosa and provide not only protection against invasive infection but also against colonization in the respiratory system. "
12/01/2000 - "The new conjugate pneumococcal vaccine (7 serogroups) has an efficacy of 90% for reducing invasive infections of Streptococcus pneumoniae. "
03/02/2021 - "This lack of broad protection highlights the necessity of improving upon the current "gold standard" pneumococcal vaccines to increase protection both by decreasing colonization and reducing the incidence of sterile-site infections. "
10/01/2011 - "Conjugate pneumococcal vaccines offer suboptimal protection against mucosal infections and are restricted in serotype and geographical coverage. "

10/01/2007 - "Pneumococcal vaccines may be effective in preventing or decreasing the burden of disease related to otitis media. "
01/01/2021 - "This new study would allow assessments of the utility of the pneumococcal vaccine in conferring its protective effects on the long-term sequelae of otitis media (OM), if any. "
03/04/2006 - "The primary endpoint was protective efficacy against the first episode of acute otitis media caused by vaccine pneumococcal serotypes. "
10/01/2023 - "Efficacy of Pneumococcal Vaccine on Otitis Media: A Systematic Review and Meta-Analysis."
01/01/2014 - "A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media."

03/01/1998 - "Even with the widespread availability and proven efficacy of influenza and pneumococcal vaccines, their use has remained suboptimal. "
04/01/2004 - "Within the first 6 months of free GMS care for all, the "new GMS" patients attended significantly more often than before with the percentage of high consulters increasing from 24% to 52% (p=0.0039), took more medications (from 1.72 to 2.2), showed improvement in all quality of care parameters (with the exception of PSA screening which remained static) and had improved attendance for influenza 40% to 62% (p=0.0277) and pneumococcal vaccines 2% to 26% (p=0.00054). "
02/01/2006 - "VA care was associated with improved influenza and pneumococcal vaccine coverage, although vaccination rates for all elderly veterans fell short of Healthy People 2010 goals. "
05/04/2002 - "Adding a pneumococcal vaccine to the influenza vaccination could decrease the degree of protection against influenza. "
02/13/2023 - "The findings of this study demonstrated that healthcare providers need to pay more attention to adhering to the global recommendations on influenza and pneumococcal vaccine among patient who were recently discharged with respiratory disease. "